P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
For decades the random 12-core biopsy has been the mainstay for diagnosing prostate cancer. Unfortunately, there is a slew of problems that comes with random biopsy, including misdiagnosis, infection, and …
Listen: https://soundcloud.com/prostate-oncology/six-not-a-bad-score “There’s rapid progress ongoing in the prostate cancer world and new treatments are being developed all the time. One of the major advantages of active surveillance is postponing …
BY MARK SCHOLZ, MD The Limitations of PSA PSA is nonspecific. Meaning it doesn’t distinguish between the harmless, low-grade type of prostate cancer that can be watched and the higher-grade …
Active Surveillance is a revolutionary concept: The thought you can monitor prostate cancer rather than treat prostate cancer. This is a surprising development because anything called cancer, one would assume …
WHAT IF I HAVE AN ELEVATED PSA So what do you do when you have a high PSA? Is simply doing a scan enough? The scan not only helps men …
IS IT POSSIBLE TO SKIP A BIOPSY? We’ve been talking a lot about the different types of biopsies – targeted vs random and all these new developments. But what’s really …
NO MORE RANDOM BIOPSIES. Over a million men get a prostate biopsy every year and quite often, in fact almost always, they are unaware of how dangerous a biopsy can …
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …
BY MARK SCHOLZ, MD The PSA assay, along with cholesterol and other tests, is a common component of the blood testing that occurs during a man’s annual physical examination. But …
BY MARK SCHOLZ, MD It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer …